|
|
||||||||
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
| |
ABSTRACT |
|---|
|
|
|---|
Epoxyeicosatrienoic acids (EETs) are
cytochrome P-450 metabolites of arachidonic acid involved in
the regulation of vascular tone. The method of microbore column
high-performance liquid chromatography with fluorescence detection was
developed to determine 14,15-EET, 11,12-EET, and the mixture of 8,9-EET
and 5,6-EET. Tridecanoic acid (TA) was used as an internal standard.
EETs were reacted with 2-(2,3-naphthalimino)ethyl
trifluoromethanesulfonate (NT) to form highly fluorescent derivatives.
A C18 microbore column and a water-acetonitrile mobile
phase were used for separation. Samples were excited at 259 nm, and the
fluorescence was detected at 395 nm. The overall recoveries were 88%
for EETs and 40% for TA. EETs were detected in concentrations as low
as 2 pg (signal-to-noise ratio = 3). The method was used to
determine the EET production from endothelial cells (ECs). Bradykinin
and methacholine (10
6 M) stimulated an increase in the
production of EETs by ECs two- and fivefold, respectively. This
sensitive method may be used for determination of EETs at low
concentrations normally detected in complex biological samples.
cytochrome P-450; endothelial cells; epoxyeicosatrienoic acids; high-performance liquid chromatography
| |
INTRODUCTION |
|---|
|
|
|---|
CYTOCHROME P-450 is one of three major groups of enzymes that can metabolize arachidonic acid to many biologically active eicosanoids (14, 19). Cytochrome P-450 metabolizes arachidonic acid to 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids (EETs), their corresponding dihydroxyeicosatrienoic acids (DHETs), and several 5-hydroxyeicosatetraenoic acids (HETEs), including 19- and 20-HETE (7, 19). This enzymatic pathway was first described in the liver (6, 18); however, it is now clear that arachidonic acid can be metabolized by cytochrome P-450 in many tissues, including the pituitary gland, eye, kidney, adrenal gland, and blood vessels (11, 17, 22). The EETs have been shown to stimulate the release of insulin and glucagon from pancreatic islet cells (10), luteinizing hormone, growth hormone, oxytocin and vasopressin from the pituitary gland (20), somatostatin and luteinizing hormone-releasing hormone from the hypothalamus (5, 27), and catecholamines from the adrenal chromaffin cells (15). The EETs are synthesized by the vascular endothelium (25, 26), and they relax vascular smooth muscle by opening potassium channels and hyperpolarizing the smooth muscle cells (4, 13, 16). It has been proposed that the EETs represent endothelium-derived hyperpolarizing factors. Despite the importance of the EETs in a variety of physiological and pharmacological effects, there have been few methods developed to quantify EETs in biological samples. The most common method for determining EETs has been the method of gas chromatography-mass spectrometry (GC-MS) (8, 12, 26, 28-30). A negative ion chemical ionization GC-MS was used to measure the urinary excretion of the EETs and their hydrolysis products, the DHETs in normal subjects, pregnant women, and women with pregnancy-induced hypertension (8). EET excretion was elevated in pregnant women and further increased in women with pregnancy-induced hypertension. Under most circumstances, the EET production in biological systems is extremely low. We have developed a fluorescence polarization immunoassay to quantify 14,15-EET and 14,15-DHET in cell cultures (21). However, the method can detect only the 14,15-EET and 14,15-DHET regioisomers. Because of the need for a very sensitive and simplified method for measuring EETs, we have developed a microbore column high-performance liquid chromatography (HPLC) assay that utilizes fluorometric detection. The carboxylic acid group of the EETs was easily reacted with 2-(2,3-naphthalimino)ethyl trifluoromethanesulfonate (NT) to produce strong fluorescent derivatives (1, 3, 31). This method allows the measurement of endogenous EETs at very low concentrations in cell culture media.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials. Four regioisomers of EETs were synthesized and purified as previously described by Corey et al. (9) and modified by Rosolowsky and Campbell (25). NT was purchased from Molecular Probes, (Eugene, OR). Tridecanoic acid (TA), methacholine, and acetonitrile (<0.005% water) were obtained from Sigma Chemical (St. Louis, MO). C18 Bond Elut solid-phase extraction (SPE) columns were purchased from Varian (Harbor City, CA). Bradykinin was obtained from Peninsula Laboratories (Belmont, CA). [3H8]14,15-EET was purchased from NEN Life Science Products (Boston, MA). Tetraethylammonium carbonate (TEAC) was synthesized as previously described by Akasaka and co-workers (2). Other chemicals or reagents were of analytic or HPLC grades. Distilled deionized water was used throughout this study.
Culture and stimulation of bovine coronary artery endothelial
cells.
Bovine hearts were obtained from a local abattoir and used immediately.
Endothelial cells (ECs) were isolated from bovine coronary arteries
using a modification of the previously described technique
(24). In general, the cells were grown in
75-cm2 flasks and used within the third passage. The
cultured media were removed from the flasks, and the cells were washed
twice with protein-free culture media. HEPES buffer (15 ml) containing bradykinin (10
6 M) or methacholine (10
6 M)
was then added and incubated at 37°C for 10 min. Cells incubated with
15 ml of HEPES buffer were used as the control. After the stimulation,
miconazole (10
5 M) was added and incubated for 10 min.
The cells were then scraped and transferred to 50-ml tubes and
sonicated briefly two times. A 50-µl aliquot of each sample was used
to determine the protein concentration using Bio-Rad protein assay
(Bio-Rad, Hercules, CA). The internal standard, 30 µl of
10
6 M TA, was added to the remaining portions of the
samples and mixed. Ethanol (5 ml) was then added to the samples, mixed,
and centrifuged at 1,500 rpm for 3 min. The supernatants were
transferred to reaction tubes and frozen at
80°C or extracted.
Solid-phase extraction. The frozen samples were allowed to thaw on ice and then applied to the C18 Bond Elut SPE columns that had been preconditioned with 5 ml of ethanol and 15 ml of water. The columns were washed with 20 ml of water and allowed to run dry. The fatty acid metabolites were then eluted from the column with 5 ml of ethyl acetate. The ethyl acetate layer was removed from the water layer at the bottom of the reaction tubes. The water layer was then extracted twice with 1 ml of ethyl acetate. The ethyl acetate portions were combined for each sample and dried under the stream of nitrogen gas.
Fluorescent derivatization.
The standards or samples were dissolved in 35 µl of acetonitrile. Ten
microliters of freshly prepared TEAC (10
3 M) in
acetonitrile was added to the solution and vortexed lightly. Freshly
prepared NT (5 µl, 10
3 M) in acetonitrile was then
added, vortexed lightly, purged with nitrogen gas, and capped. The
reaction tubes were placed in the dark at room temperature for various
times in the time course study or for 15 min in the remaining
experiments. This reaction is very sensitive to moisture. Therefore, it
must be performed in a dry environment. After the reaction, the samples
were transferred to the inserts in the sample vials. They were then
frozen at
80°C or analyzed by HPLC.
HPLC. The EET standards and samples were analyzed on the Hewlett-Packard 1090 Series II liquid chromatograph (Hewlett-Packard, Palo Alto, CA) using an autosampler. The typical injection volume was 2 µl. A microbore column Luna C18 (2) (250 × 1.0 mm, 5 µm) (Phenomenex, Torrance, CA) with water-acetonitrile mobile phase was used for separation. The gradient started from 50% A (acetonitrile) and 50% B (water) and linearly increased to 75% A over 30 min, 75% A to 85% A over 70 min, 85% A to 100% A over 20 min, and held for 20 min. The flow rate was 60 µl/min. The fluorescence was detected with the Hewlett-Packard 1046A programmable fluorescence detector at the excitation wavelength 259 nm and the emission wavelength 395 nm with a 370-nm long-pass filter. The chromatograms were recorded and analyzed by a Hewlett-Packard Chem Station. A separate mobile phase system was also used to verify the identities of chromatographic peaks in the samples. Therefore, some samples were reanalyzed using an isocratic mobile phase of 70% A and 30% B.
| |
RESULTS |
|---|
|
|
|---|
Sample extraction and recovery. The extraction recovery of EETs using the C18 SPE columns was investigated by extracting [3H8]14,15-EET in HEPES buffer at various percentages of ethanol. The EET recoveries of 51%, 95%, and 73% were obtained at 15%, 25%, and 35% of ethanol content, respectively. Therefore, 25% ethanol was used in this study to optimize the recovery of EETs. Adjusting the ethanol concentration allowed good extraction of the EETs without the need for acidifying the sample thus reducing the hydrolysis of EETs to DHETs.
The overall recoveries were obtained from the addition of the known amount of standard EETs to the samples. They were then extracted, reacted with NT, and analyzed. The peak areas were compared with the peak areas of standards without extraction. The overall recoveries of EETs in the range of 25-125 pg were 88% for 14,15-EET, 84% for 11,12-EET, 89% for 8,9-EET, and 83% for 5,6-EET, whereas the overall recovery of TA was 40% (n = 6). These recoveries of analytes and internal standard were used for correcting the measured amount of EETs in the samples.Fluorescent derivatization and reaction product identification.
The reaction of EETs with NT using TEAC catalyst is shown in Fig.
1A. This reaction is extremely
sensitive to moisture. The reagents and solvents must be moisture free,
and the reaction must be performed in a dry environment. The reaction
of NT with EETs gave the highest yield when the concentration of TEAC
was two times greater than NT. This result was similar to the labeling of carboxylic acids with 2-(2,3-anthracenedicarboximido)ethyl trifluoromethanesulfonate as previously described (1). The ratio of TEAC to NT was kept at 2: 1 throughout these studies.
|
18 + 1)+; loss of water], and 561 [(M + 18)+; water adduct of the EET-NT].
There are several minor ions at m/z = 303 (EET
moiety
oxygen), 285 (subsequent loss of water from 303), and
224 (NT moiety: fragment between CH2-O of the NT and EET).
These data confirm the formation of the 14,15-EET-NT product.
The derivatization of EETs and TA with NT rapidly increased with time.
The maximal yield was obtained at 10-15 min at room temperature
and slightly decreased after 2 h. Figure
2 shows the reaction rate of 14,15-EET
with NT and TEAC as a catalyst. Similar results were obtained with the
other EET regioisomers.
|
Standard curve and detection limit.
Typical standard curves for the four EET regioisomers are shown in Fig.
3. The curves of regioisomeric EETs are
identical and linear from 5 to 200 pg. The limit of detection
(signal-to-noise ratio = 3) of 2 pg was achieved for all four
regioisomeric EETs. These measurements were separately performed with
each EET standard. The 8,9-EET-NT and 5,6-EET-NT were not resolved in
this study and were analyzed as the mixture of these two regioisomers.
|
HPLC separation.
Separation of EETs and TA from more abundant contaminating fatty acids
was achieved by using a gradient of acetonitrile and water. The
fluorescent products of 14,15-EET, 11,12-EET, and TA were well resolved
from the products of 5,6-EET and 8,9-EET. Table 1 shows the retention times of NT
products of these four regioisomers of EET and TA. This HPLC system
provides an ability to identify and quantify 14,15-EET, 11,12-EET, and
the mixture of 8,9-EET and 5,6-EET. The EET concentrations and their
identities were obtained by comparing their peak areas and their
retention times to the known standards. In some cases, the identities
of the peaks were also confirmed by adding known EET standards to the
samples before extraction. Figure 4 shows
the chromatograms of four regioisomers of EET-NTs (Fig. 4A)
and the methacholine-stimulated sample-NT (Fig. 4B).
The sample contained a peak that matched the 14,15-EET-NT at 70.42 min
and a peak that matched the TA-NT at 92.03 min. It also had a peak at
the similar retention time of 8,9- and 5,6-EET-NT (77.39 min). However,
the control cells (without stimulation) also had the peak at 77.39 min.
|
|
Production of EETs by endothelial cells.
On stimulation of ECs with either bradykinin or methacholine, a marked
increase in EETs was observed. Figure 5
shows the production of 14,15-EET by ECs stimulated with bradykinin and
methacholine. The control ECs produced only small amounts of EETs. The
major EET was identified as 14,15-EET. Other isomers of EET were
present at a concentration too low for quantitation. Both
bradykinin and methacholine at 10
6 M stimulated 14,15-EET
production. Methacholine increased the release of 14,15-EET by fivefold
(P < 0.01), whereas bradykinin caused a twofold
increase.
|
| |
DISCUSSION |
|---|
|
|
|---|
The amount of ethanol in the sample before the extraction with SPE columns was critical for the recoveries of both EETs and TA. This finding is similar to previous reports for other eicosanoids (23). Too low an amount of ethanol may not completely dissolve EETs and too high an amount of ethanol may prevent adsorption of EETs to the SPE columns. The 25% ethanol content was used for a maximal recovery of EETs with a lower recovery of the more hydrophobic TA.
NT was chosen as the fluorescent conjugating probe because its reaction
products have a relatively high stability, a high molar absorptivity,
and a strong fluorescence. In addition, it has a short excitation
wavelength (259 nm) and a long emission wavelength (395 nm). This
allowed the use of wider detector slits to obtain higher sensitivity.
TEAC was used as a catalyst as suggested by Akasaka and co-workers
(1) for conjugating fatty acids with 2-(2,3-anthracenedicarboximido)ethyl trifluoromethanesulfonate. Because
the reaction is moisture sensitive, it must be performed in a dry
environment. The NT and TEAC reagents should be freshly prepared.
Prolonged storage of these reagents resulted in the breakdown of NT and
lower yields of the reaction products. The reacted samples should be
kept at
80°C until analysis. A long storage of samples at room
temperature resulted in more fluorescence background peaks.
The derivatization reaction took place very rapidly, and the maximal
fluorescence signal was obtained after 10 min. Therefore, the samples
were reacted with NT for 15 min and frozen at
80°C until analysis.
There was no significant difference in the extent of derivatization
between the four regioisomers of EET.
A C18 reverse-phase microbore column with water-acetonitrile mobile phase greatly improved the resolution and sensitivity of these compounds. It is difficult to resolve the four regioisomers of EETs from each other and from other more abundant fatty acids using an analytic (4.6 × 250 mm) HPLC column. Despite the high resolution of the microbore column technique, contaminating fatty acids were detected in some samples that comigrated with 5,6- and 8,9-EET; thus, a second mobile phase was required to confirm the identities of the peaks.
The control ECs produced very low concentrations of EETs. However, the EET production significantly increased when ECs were stimulated with methacholine. Bradykinin also stimulated EET production but was less effective than methacholine. This may be due to the metabolism of bradykinin by ECs. The major EET released from ECs was identified as 14,15-EET, whereas other regioisomeric EETS were probably produced at too low concentrations for detection.
In conclusion, we demonstrate that very low concentrations of EETs can be determined in biological samples by using a microcolumn HPLC and fluorescence detection. The microbore column improves the sensitivity and separation of fatty acids. Despite the high interference from more abundant fatty acids, this method provides good separation in the chromatographic range for the EET peaks. This high resolution cannot be obtained from an analytic column. Some disadvantages are that the microcolumn requires a good pumping system at a low flow rate and long run time for reproducible retention time and sample resolution. However, it is a powerful tool for determination of the regulation of EET release from cells and tissues that other methods cannot achieve.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Dr. Hiroshi Ohrui (Dept. of Applied Biological Chemistry, Faculty of Agriculture, Tohoku University, Japan) for generosity in providing some TEAC and suggestions; Dr. Alexander Schilling (Agilent Technologies,) for the liquid chromatography- mass spectrometry analysis of the reaction products; Donn R. Halla and Blythe B. Holmes for technical assistance; and Gretchen Barg for secretarial assistance.
| |
FOOTNOTES |
|---|
These studies were supported by National Heart, Lung, and Blood Institute Grant HL-51055.
Address for reprint requests and other correspondence: W. B. Campbell, Dept. of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226 (E-mail: wbcamp{at}mcw.edu)
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 29 February 2000; accepted in final form 12 April 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Akasaka, K,
Ohrui H,
and
Meguro H.
Determination of carboxylic acids by high-performance liquid chromatography with 2-(2,3-anthracenedicarboximido)ethyl trifluoromethanesulfonate as a highly sensitive fluorescent labeling reagent.
Analyst
118:
765-768,
1993.
2.
Akasaka, K,
Suzuki T,
Ohrui H,
Meguro H,
Shindo Y,
and
Takahashi H.
9-Bromomethylacridine, a novel fluorescent labeling reagent of carboxylic group for HPLC.
Anal Lett
20:
1581-1594,
1987.
3.
Akasaka, K,
Ohrui H,
Meguro H,
and
Yasumoto T.
Fluorometric determination of diarrhetic shellfish toxins in scallops and mussels by high-performance liquid chromatography.
J Chromatogr A
729:
381-386,
1996[Web of Science][Medline].
4.
Campbell, WB,
Gebremedhin D,
Pratt PF,
and
Harder DR.
Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.
Circ Res
78:
415-423,
1996
5.
Capdevila, J,
Chacos N,
Falck JR,
Manna S,
Negro-Vilar A,
and
Ojeda SR.
Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence.
Endocrinology
113:
421-423,
1983
6.
Capdevila, J,
Chacos N,
Werringloer J,
Prough RA,
and
Estabrook RW.
Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid.
Proc Natl Acad Sci USA
78:
5362-5366,
1981
7.
Capdevila, JH,
Falck JR,
and
Estabrook RW.
Cytochrome P450 and the arachidonate cascade.
FASEB J
6:
731-736,
1992[Abstract].
8.
Catella, F,
Lawson JA,
Fitzgerald DJ,
and
Fitzgerald GA.
Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension.
Proc Natl Acad Sci USA
87:
5893-5897,
1990
9.
Corey, EJ,
Niwa H,
and
Falck JR.
Selective epoxidation of eicosa-cis-5,8,11,14-trienoic acid.
J Am Chem Soc
101:
1586-1587,
1979.
10.
Falck, JR,
Manna S,
Moltz J,
Chacos N,
and
Capdevila J.
Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets.
Biochem Biophys Res Commun
114:
743-749,
1983[Web of Science][Medline].
11.
Fitzpatrick, FA,
and
Murphy RC.
Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids.
Pharmacol Rev
40:
229-241,
1988[Web of Science][Medline].
12.
Fulton, D,
Falck JR,
McGiff JC,
Carroll MA,
and
Quilley J.
A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol.
J Lipid Res
39:
1713-1721,
1998
13.
Gebremedhin, D,
Ma Y-H,
Falck JR,
Roman RJ,
VanRollins M,
and
Harder DR.
Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle.
Am J Physiol Heart Circ Physiol
263:
H519-H525,
1992
14.
Harder, DR,
Campbell WB,
and
Roman RJ.
Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the vascular tone.
J Vasc Res
32:
79-92,
1995[Web of Science][Medline].
15.
Hildebrandt, E,
Albanesi JP,
Falck JR,
and
Campbell WB.
Regulation of calcium influx and catecholamine secretion in chromaffin cells by a cytochrome P450 metabolite of arachidonic acid.
J Lipid Res
36:
2599-2608,
1995[Abstract].
16.
Hu, S,
and
Kim HS.
Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid.
Eur J Pharmacol
230:
215-221,
1993[Web of Science][Medline].
17.
Judd, AM,
Spangelo BL,
Ehreth JT,
and
MacLeod RM.
A possible role for lipoxygenase and epoxygenase arachidonate metabolites in prolactin release from pituitary cells.
Neuroendocrinology
48:
407-416,
1988[Web of Science][Medline].
18.
Laniado-Schwartzman, M,
Davis KL,
McGiff JC,
Levere RD,
and
Abraham NG.
Purification and characterization of cytochrome P-450-dependent arachidonic acid epoxygenase from human liver.
J Biol Chem
263:
2536-2542,
1988
19.
McGiff, JC.
Cytochrome P-450 metabolism of arachidonic acid.
Annu Rev Pharmacol Toxicol
31:
339-369,
1991[Web of Science][Medline].
20.
Negro-Vilar, A,
Snyder GD,
Falck JR,
Manna S,
Chacos N,
and
Capdevila J.
Involvement of eicosanoids in release of oxytocin and vasopressin from the neutral lobe of the rat pituitary.
Endocrinology
116:
2663-2668,
1985
21.
Nithipatikom, K,
Falck JR,
Bhatt RK,
Hanke CJ,
and
Campbell WB.
Determination of 14,15-epoxyeicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acid by fluoroimmunoassay.
Anal Biochem
246:
253-259,
1997[Web of Science][Medline].
22.
Oyekan, AO,
McGiff JC,
and
Quilley J.
Cytochrome P-450-dependent vasodilation of rat kidney by arachidonic acid.
Am J Physiol Heart Circ Physiol
261:
H714-H719,
1991
23.
Powell, WS.
Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica.
Methods Enzymol
86:
467-477,
1982[Web of Science][Medline].
24.
Revtyak, GE,
Johnson AR,
and
Campbell WB.
Cultured bovine coronary arterial endothelial cells synthesize HETEs and prostacyclin.
Am J Physiol Cell Physiol
254:
C8-C19,
1988
25.
Rosolowsky, M,
and
Campbell WB.
Role of PGI2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid.
Am J Physiol Heart Circ Physiol
264:
H327-H335,
1993
26.
Rosolowsky, M,
and
Campbell WB.
Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells.
Biochim Biophys Acta
1299:
267-277,
1996[Medline].
27.
Snyder, GD,
Capdevila J,
Chacos N,
Manna S,
and
Falck JR.
Action of luteinizing hormone-releasing hormone: involvement of novel arachidonic acid metabolites.
Proc Natl Acad Sci USA
80:
3504-3507,
1983
28.
Turk, J,
Stump WT,
Conrad-Kessel W,
Seabold RR,
and
Wolf BA.
Quantitation of epoxy- and dihydroxyeicosatrienoic acids by stable isotope-dilution mass spectrometry.
Methods Enzymol
187:
175-186,
1990[Web of Science][Medline].
29.
VanRollins, M,
and
Knapp HR.
Identification of arachidonate epoxides/diols by capillary chromatography-mass spectrometry.
J Lipid Res
36:
952-966,
1995[Abstract].
30.
VanRollins, M,
Kochanek PM,
Evans RW,
Schiding JK,
and
Nemoto EM.
Optimization of epoxyeicosatrienoic acid syntheses to test their effects on cerebral blood flow in vivo.
Biochim Biophys Acta
1256:
263-274,
1995[Medline].
31.
Yasaka, Y,
Tanaka M,
and
Shono T.
2-(2,3-Naphthalimino) ethyl trifluoromethanesulfonate as a highly reactive ultraviolet and fluorescent labeling agent for the liquid chromatographic determination of carboxylic acids.
J Chromatogr A
508:
133-140,
1990.
This article has been cited by other articles:
![]() |
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ben-Amor, P. C. Redondo, A. Bartegi, J. A. Pariente, G. M. Salido, and J. A. Rosado A role for 5,6-epoxyeicosatrienoic acid in calcium entry by de novo conformational coupling in human platelets J. Physiol., January 15, 2006; 570(2): 309 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, S. Hu, B. Xu, G. D. Snyder, S. Harmon, J. Yao, Y. Liu, B. Sangras, J. R. Falck, N. L. Weintraub, et al. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-{alpha} Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H55 - H63. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Falck, U. M. Krishna, Y. K. Reddy, P. S. Kumar, K. M. Reddy, S. B. Hittner, C. Deeter, K. K. Sharma, K. M. Gauthier, and W. B. Campbell Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H337 - H349. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, N. L. Weintraub, C. L. Oltman, L. L. Stoll, T. L. Kaduce, S. Harmon, K. C. Dellsperger, C. Morisseau, B. D. Hammock, and A. A. Spector Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2306 - H2314. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.-C. Lee, and M. VanRollins Cytochrome P-450 Epoxygenase Metabolites of Docosahexaenoate Potently Dilate Coronary Arterioles by Activating Large-Conductance Calcium-Activated Potassium Channels J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 768 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Newman, T. Watanabe, and B. D. Hammock The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS J. Lipid Res., September 1, 2002; 43(9): 1563 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhu, C. Zhang, M. Medhora, and E. R. Jacobs CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium J Appl Physiol, July 1, 2002; 93(1): 330 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell, C. Deeter, K. M. Gauthier, R. H. Ingraham, J. R. Falck, and P.-L. Li 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of KCa channels Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1656 - H1664. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |